Skip to main content
. 2018 Sep 14;18:65. doi: 10.1186/s12902-018-0289-4

Table 4.

Associations of XbaI genotypes with various clinical characteristics

Variables AA (n = 74) AG (n = 154) GG (n = 76)
Age (years) 62.14 ± 4.24 63.24 ± 4.85 63.11 ± 3.75
BMI (kg/m2) 22.97 ± 2.99 23.98 ± 3.40* 24.71 ± 3.18*
Waist circumference (cm) 84.26 ± 5.36 84.92 ± 5.13 86.07 ± 4.96*
FBG (mM) 4.95 ± 0.88 5.21 ± 1.41* 5.70 ± 1.10*#
HbA1C (%) 5.89 ± 1.00 5.94 ± 1.05 6.09 ± 0.98
Systolic blood pressure (mmHg) 132.31 ± 14.39 134.15 ± 13.96 139.05 ± 14.12*#
Diastolic blood
pressure (mmHg)
79.95 ± 11.96 81.14 ± 11.39 85.86 ± 10.69*#
Triglycerides (mM) 1.84 ± 0.92 2.08 ± 1.20* 2.38 ± 1.16*
Total cholesterol (mM) 4.29 ± 1.20 4.72 ± 0.83* 5.53 ± 1.12*#
HDL-C (mM) 1.25 ± 0.26 1.15 ± 0.21* 1.06 ± 0.20*#
LDL-C (mM) 2.74 ± 0.64 2.83 ± 0.67 3.39 ± 0.83*#
NAFLD (%) 28 (37.8) 70 (45.5) 45 (59.2)*
Fasting serum
insulin (μIU/mL)
11.15 ± 5.68 11.54 ± 6.23 12.54 ± 8.31
Estradiol (pg/ml) 26.82 ± 6.99 24.66 ± 7.48 24.49 ± 7.67
HOMA-IR 2.47 ± 1.32 2.72 ± 1.77* 3.20 ± 1.70*

Measurement data are mean ± SD, and were assessed by one way ANOVA with post-hoc SNK test

*Significant difference from patients harboring AA (p < 0.05)

#Significant difference from patients harboring AG (p < 0.05). Enumeration count data were described as rate, and assessed by the chi-square test